These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34977179)

  • 1. The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy.
    Aguiar Rosa S; Thomas B; Fiarresga A; Papoila AL; Alves M; Pereira R; Branco G; Cruz I; Rio P; Baquero L; Ferreira RC; Mota Carmo M; Lopes LR
    Front Cardiovasc Med; 2021; 8():761860. PubMed ID: 34977179
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
    JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction.
    Li Y; Liu J; Cao Y; Han X; Shao G; Zhou X; Gu J; Liu T; Cui Y; Shi H
    Sci Rep; 2021 Feb; 11(1):4297. PubMed ID: 33619345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Aguiar Rosa S; Mota Carmo M; Rocha Lopes L; Oliveira E; Thomas B; Baquero L; Cruz Ferreira R; Fiarresga A
    Rev Port Cardiol; 2022 Sep; 41(9):761-767. PubMed ID: 36066271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy.
    Ye Y; Ji Z; Zhou W; Pu C; Li Y; Zhou C; Hu X; Chen C; Sun Y; Huang Q; Zhang W; Qian Y; Ren H; Yu F; Jiang C; Mao Y; Wang B; Augusto JB; Lai D; Hu H; Fu GS
    Front Cardiovasc Med; 2021; 8():758635. PubMed ID: 34869672
    [No Abstract]   [Full Text] [Related]  

  • 9. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
    Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
    Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
    Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
    Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis.
    Galli E; Vitel E; Schnell F; Le Rolle V; Hubert A; Lederlin M; Donal E
    Echocardiography; 2019 Jan; 36(1):74-82. PubMed ID: 30488501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis.
    Garcia Brás P; Aguiar Rosa S; Thomas B; Fiarresga A; Cardoso I; Pereira R; Branco G; Cruz I; Baquero L; Cruz Ferreira R; Mota Carmo M; Rocha Lopes L
    Rev Port Cardiol; 2022 Jul; 41(7):559-568. PubMed ID: 36065775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
    Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
    Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.